<p>Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]</p>

Reynold A Panettieri Jr; Tobias Welte; Kartik V Shenoy; Stephanie Korn; Margret Jandl; Edward M Kerwin; Rosa Feijoo; Peter Barker; Richard F Olsson; Ubaldo J Martin

doi:10.2147/JAA.S251079

Back to Journals » Journal of Asthma and Allergy » Volume 13

Corrigendum

Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]

Authors Panettieri RA Jr , Welte T , Shenoy KV, Korn S, Jandl M, Kerwin EM , Feijoo R, Barker P, Olsson RF, Martin UJ

Received 24 February 2020

Accepted for publication 24 February 2020

Published 13 March 2020 Volume 2020:13 Pages 135—136

DOI https://doi.org/10.2147/JAA.S251079

Download Article [PDF]

Panettieri RA Jr, Welte T, Shenoy KV, et al. J Asthma Allergy. 2020;13:115–126.

The authors have advised that the symbol shown on page 124, discussion section, left column, line 5 “≥20%” should read “<20%”.

Read the original article

Creative Commons License © 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]